Nasdaq Halts KaloBios Pharmaceuticals, Inc.

NEW YORK, Dec. 17, 2015 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) at 06:48:07 Eastern Time for "additional information requested" from the company at a last price of $23.59.

Trading will remain halted until KaloBios Pharmaceuticals, Inc. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]

You May Also Be Interested In

• Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient
• Access Advance Welcomes New Licensors to the Video Distribution Patent Pool
• International Spirits Competition "SFWSC2026" CHOYA Have Won 2 DOUBLE GOLD Awards for "The CHOYA AGED 3 YEARS EXTRA FRUIT" & "The CHOYA GOLDEN UME FRUIT" and a GOLD A